Oncology Medicines Export Services from India
Exporting oncology medicines carries additional complexity — strict cold chain requirements, batch-specific potency documentation, and often, named-patient import pathways for unregistered biologics. The Indian Pharma provides specialized oncology export services for hospitals, distributors, and NGOs sourcing chemotherapy and biologic cancer treatment from India.
What Our Oncology Export Service Covers
| Service Component | Detail |
|---|---|
| Chemotherapy & biologic sourcing | Platinum agents through checkpoint inhibitors |
| GDP-compliant cold chain | Validated 2–8°C, 15–25°C, and -20°C ranges |
| Batch-specific documentation | COA, potency validation, WHO-GMP certification |
| Named-patient import support | For biologics unregistered in destination country |
Who Uses This Service
| Buyer Type | Typical Use Case |
|---|---|
| Hospital oncology departments | Complete cancer treatment formulary sourcing |
| Distributors | Bulk chemotherapy and biologic export |
| NGOs | Oncology access-program supply |
| Named-patient buyers | Compassionate-use import for unregistered biologics |
FAQs
Do you handle cold chain for all oncology biologics?
Yes, every temperature-sensitive oncology product ships under GDP-compliant, validated cold chain logistics.
Can NGOs source oncology medicines for access programs?
Yes, with bulk and tender pricing structures available for program-scale oncology procurement.
Is named-patient import supported for unregistered biologics?
Yes, we guide buyers through the compassionate-use and named-patient import process where local registration isn't yet in place.
Do you supply both chemotherapy and biologic immunotherapy?
Yes, our oncology export range spans foundational chemotherapy agents through to advanced checkpoint inhibitor biologics.
How do you verify manufacturer accreditation for oncology products?
We re-verify each manufacturer's WHO-GMP or relevant certification status per shipment, not just at initial onboarding, to ensure documentation stays current.
